NCT03734354View on ClinicalTrials.gov

The Pharmacokinetics, Tolerability and Safety of Brexpiprazole in Healthy Chinese Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

April 7, 2019

Primary Completion Date

May 18, 2020

Study Completion Date

May 18, 2020

Conditions
Health
Interventions
DRUG

Brexpiprazole

Brexpiprazole , single/oral/with fasting

Trial Locations (1)

100088

Beijing Anding Hospital of Capital Medical University, Beijing

Sponsors
All Listed Sponsors
lead

Otsuka Beijing Research Institute

INDUSTRY

NCT03734354 - The Pharmacokinetics, Tolerability and Safety of Brexpiprazole in Healthy Chinese Subjects | Biotech Hunter | Biotech Hunter